regimen while continuing to test three doses in the same age group. federal regulators hope it will be granted by the end of this month. let s start with this question. i wrote this down to make sure i got it right here. when pfizer released their findings in december, they found in children 6 months to 2 years, just a tenth of the adult dose created immune responses to those 16 to 25. not as strong in kids 2 to 4. that s why they are testing a third dose. they don t have the results from that. they will apply for this eua any way. should they wait for those or do you support that application coming in as soon as today? victor, that is a bit confusing, isn t it? a lot of us are scratching our heads and waiting to see the data on what basis would pfizer like to go ahead by a two dose
light a match for a larger movement, and bring people together and radicalize them. i think it s important to point out that these people are, there are exceptions, 80% of canadians are vaccinated, 90% of truckers are vaccinated, they re vaccinated a higher rate than the population, the canadian you know supported, the teachers union don t support it, and yet it continues. ruth ben-ghiant, thanks for joining us tonight, professor ruth ben-ghiant, is professor of history at new york university. one more quick thing on covid before we go, parents of young kids have anxiously waited the day that the covid vaccine is approved for kids under five. fortunately, the days gonna come a bit later than expected, pfizer announced today that it postponed its application to the fda for the vaccine to be distributed to children under the age of five. they want to wait for more data to come in, to see of young kids benefit from a three dose regimen, instead of just the standard too. and that is expe
has hit a few stumbling blocks. pfizer announced the initial 2 dose regimen for kids 2 to 4 failed to produce enough antibodies against covid. as a result, the company began testing a three-dose regiment which they show to be more effective. pfizer is hope the fda will approve as early as the next couple of weeks, the two dose regimen for now, and they say they are hopeful they will do that which will clear the way for approval of the three-dose regimen later this spring. and we did talk to parents of young children under 5 who may be eligible for the vaccine, and take a listen to what they had to say. any vaccine that my pediatrician has told me the kids needed when they were babies, they got so many, and then there were two and whatever the course is, and you know, i listen to the professionals that are delivering the baby and taking care of the babies and know about that type of health
pfizer to submit their two dose data to them for authorization, they said in part this afternoon that the fda felt it was their responsibility as a public health agency to act with urgency and have all available options including they provide us with initial data on two doses from the on going study, their goal was to understand if two dose was provide sufficient protection. remember, we had press release information already in december from pfizer that said, you know, there two dose regimen in this age-group did not trigger a comparable immune response as what was seen in 16 to 25-year-olds. typically what happens in these cases with the trials is they use that immune response as a surrogate marker in something called immunobridging to predict in that age-group that dose would actually illicit an adequate response. they got a lot more data now because of the omicron surge and
were disappointing. the studies show that for kids between 2 and 5 come of the two dose regimen did not provide the needed protection against symptomatic covid-19. so while the fda is likely to approve two shots for young children beginning as early as march, the ceo of pfizer has already said a third shot will be necessary and now the fda is saying come according here we want to set the record straight on the reason pfizer covid-19 vaccine for children six months to four years. nothing has changed about a process for evaluating covid-19 vaccines and we are not changing our rigorous scientific standards, except maybe it is why cnn s medical analyst and former planned parenthood doctor is now hesitant. watch. i am ambivalent right now which is not something i ever thought i would say about vaccines for under 5-year-olds. i am the mom of two little kids